+142.0%
CNP vs GSK
+105.0%
+37.0%
-59.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.6% | +0.5% | +0.1% | +0.4% |
| 7D | +1.3% | +1.1% | +0.2% | +0.9% |
| 30D | +3.8% | +6.3% | -2.5% | +1.2% |
| 3M | +2.4% | +1.8% | +0.5% | +1.2% |
| 6M | -1.2% | +1.7% | -2.8% | -2.5% |
| YTD | +9.3% | +6.5% | +2.7% | +4.9% |
| 1Y | +6.4% | +9.5% | -3.1% | +0.9% |
| 3Y | +66.4% | +65.3% | +1.0% | +25.0% |
| 5Y | +75.7% | +43.7% | +31.9% | +38.9% |
| All | +142.0% | +105.0% | +37.0% | +62.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling